Leukogene Therapeutics welcomes industry veteran and leader Dr. Sandeep Gupta as its Chief Executive Officer

Dr. Nathan Dolloff of MUSC and Leukogene Therapeutics Inc. awarded SCRA grant for development of MHC class II targeted cancer immunotherapy